Editorial & Advertiser disclosure

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Research Reports

Atopic Dermatitis Market to Reach $19.49 Billion by 2034 with 4.3% CAGR

Published by Jessica Weisman-Pitts

Posted on April 3, 2025

Featured image for article about Research Reports

Rising cases of allergic reactions and eczema are set to boost the atopic dermatitis market size from US$ 12.73 billion in 2024 to US$ 19.49 billion by 2034, says Fact.MR, a market research and competitive intelligence provider in its recently updated report.

For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=4603

Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=S&rep_id=4603

Inflammatory skin disease treatment market is estimated to stand at US$ 27.68 billion in 2024 and is slated to increase at a CAGR of 13.5% to reach US$ 97.89 billion by 2034.

Skin barrier market size is anticipated to be valued at US$ 373.4 million in 2024. It is estimated to reach a valuation of US$ 540.9 million by 2034, projected at a CAGR of 3.8% from 2024 to 2034.

Allergy care market is estimated at USD 22 Billion in 2022 and is forecast to surpass USD 40 Billion by 2032, growing at a CAGR of 6.1% from 2022 to 2032.

Dermatology CRO Market size was valued at US$ 4.0 Billion in 2021, and is projected to reach US$ 12.8 Billion by 2032, with a projected compound annual growth rate (CAGR) of 9.1% during the forecast period from 2023 to 2032.

Allergy shot market is expected to reach a valuation of US$ 1.84 billion in 2024 and further expand at a CAGR of 6.1% to end up at US$ 3.34 billion by 2034.

Skin bioactive ingredients market was valued at US$ 8,833 Million in 2024 and has been forecast to expand at a noteworthy CAGR of 7.2% to reach a valuation of US$ 17,737 Million by 2034.